Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q1 2024 Earnings Call Transcript May 15, 2024
Panbela Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-2.28 EPS, expectations were $-1.23.
Operator: Good afternoon, everyone, and welcome to the Panbela Therapeutics First Quarter 2024 Earnings Call. [Operator Instructions]. I will now turn the conference over to your host, James Carbonara, Investor Relations. James, over to you.
James Carbonara: Thank you, operator. Joining me on...
